[Intravenous thrombolytic therapy with Revelisa of ischemic stroke in real-world clinical practice: interim results of an open-label, prospective, multicenter, non-interventional study IVT-AIS-R].
M A SoldatovN A MarskayaK A BarsegovaO V AndrofaginaD N BorisovD Yu KarpovM V KishinevskyM V KucheryavayaS V TabakmanYu A TelyatnikA S FadeevaD S KhanA N ChirkovN A ShamalovPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2021)
The data obtained with the use of Revelisa in patients with ischemic stroke in real-world clinical practice allow drawing conclusions about a comparable safety and efficacy profile to that in previously published registry studies of alteplase.